Author/Authors
Uçucu, Mehmet Istanbul Education and Research Hospital - Clinic of Internal Medicine, Turkey , Öner, Fatma Alibaz Istanbul Education and Research Hospital - Clinic of Internal Medicine, Turkey , Yurdakul, Selen Istanbul Education and Research Hospital - Cardiology, Turkey , Ergüney, Mecdi Istanbul Education and Research Hospital - Clinic of Internal Medicine, Turkey
Title Of Article
IN-HOSPITAL MORTALITY IN PATIENTS WITH IMPAIRED FASTING GLUCOSE AND ACUTE CORONARY SYNDROMES
شماره ركورد
35086
Abstract
Objectives: Diabetes mellitus is considered to be equivalent to coronary artery disease(CHD). Both impaired fasting glucose(IFG) and impaired glucose tolerance (IGT) are risk factors for cardiovascular disease. We aimed to compare the mortality during hospitalization between IFG and diabetes in patients with acute coronary syndrome (ACS). Methods: The patients under 65 years of age, who had been diagnosed as ACS; were evaluated for mortality during the first 7 days. The patients were divided into three groups as the first group diabetic, the second group non-diabetic patients , the patients with IFG. Results: A total of 375 patients were enrolled. The mortality rate was found to be 6.7% in patients with diabetes, 2.6% in patients without diabetes , 7.0% in patients with an IFG. The mortality rate of the patients with IFG and the patients with diabetes were approximately the same and this rate was significantly higher than in those with normal blood glucose during the acute phase of ACS. Conclusion: The IFG affects mortality as much as diabetes. Fasting plasma glucose is beneficial, in determining the cardiovascular risks and in the modification of the therapy to reduce the risk of CHD.
From Page
257
NaturalLanguageKeyword
Acute coronary syndrome , Impaired fasting glucose , Diabetes , Mortality
JournalTitle
Marmara Medical Journal
To Page
262
JournalTitle
Marmara Medical Journal
Link To Document